The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer. 2018

Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
Department of Obstetrics & Gynecology, The Affiliated Hospital of Jiangnan University, Wuxi 214062, China.

OBJECTIVE We aim to investigate the functions of PXN in cervical cancer. METHODS PXN protein was investigated by immunohistochemistry in a panel of cervical cancer. A series of in vitro and in vivo assays were used to explore the efficacy of PXN. RESULTS PXN was significantly upregulated in cervical cancer, which associated with tumor stage, poor differentiation, lymphovascular space invasion and lymphatic metastasis. Knockdown of PXN notably impaired cellular growth and colony formation by suppressing Bcl-2 and inducing marked apoptosis. Moreover, PXN led to resistance to radiation, and downregulation of PXN resensitized C33A cells to radiation. CONCLUSIONS PXN was frequently upregulated and acted as an oncogene via regulating Bcl-2 in cervical cancer, which supports PXN as a potent therapeutic target.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
October 2018, Radiation oncology (London, England),
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
July 2022, Experimental and molecular pathology,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
January 2021, International journal of radiation biology,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
February 2013, International journal of molecular medicine,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
January 2019, Cancer cell international,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
January 2024, Technology in cancer research & treatment,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
July 2011, Biochemical and biophysical research communications,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
January 2019, International journal of molecular medicine,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
February 2024, Environmental toxicology,
Qiuli Liu, and Jing Wang, and Mei Tang, and Ling Chen, and Xiaowei Qi, and Juan Li, and Jinjin Yu, and Haifeng Qiu, and Yuan Wang
September 2017, Cell cycle (Georgetown, Tex.),
Copied contents to your clipboard!